Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritin

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 294, Issue 3, 2008, Pages

  Coffman, Lan G ^a   Brown, Julie C ^a   Johnson, David A ^b   Parthasarathy, Narayanan ^a   D'Agostino Jr , Ralph B ^a   Lively, Mark O ^a   Hua, Xiaoyang ^d   Tilley, Stephen L ^d   Muller Esterl, Werner ^c   Willingham, Mark C ^a   Torti, Frank M ^a   Torti, Suzy V ^a,e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b East Tennessee State University   (United States)

^c GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Bradykinin; Inflammation

Indexed keywords

APOFERRITIN; ELASTASE; FERRITIN; HIGH MOLECULAR WEIGHT KININOGEN; TRYPTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; FERRITINS; HUMANS; IMMUNOPRECIPITATION; INFLAMMATION; KININOGEN, HIGH-MOLECULAR-WEIGHT; MACROPHAGES, ALVEOLAR; MICE; OXIDATION-REDUCTION; PANCREATIC ELASTASE; PEROXIDASE; PROTEIN BINDING; SUCCINIMIDES; TRYPTASES; ZINC;

EID: 41549140461     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00347.2007     Document Type: Article

References (57)

1. Astern JM, Pendergraft WF 3rd, Falk RJ, Jennette JC, Schmaier AH, Mahdi F, Preston GA. Myeloperoxidase interacts with endothelial cellsurface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system. Am J Pathol 171: 349-360, 2007.
2. Barnes PJ. Effect of bradykinin on airway function. Agents Actions Suppl 38: 432-438, 1992.
3. Barnes PJ, Chung KF, Page CP. Inflammatory mediators of asthma: an update. Pharmacol Rev 50: 515-596, 1998.
4. Campbell EJ, Silverman EK, Campbell MA. Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J Immunol 143: 2961-2968, 1989.
5. Chao J, Simson JA, Chung P, Chen LM, Chao L. Regulation of kininogen gene expression and localization in the lung after monocrotaline-induced pulmonary hypertension in rats. Proc Soc Exp Biol Med 203: 243-250, 1993.
6. Chavakis T, Kanse SM, Pixley RA, May AE, Isordia-Salas I, Colman RW, Preissner KT. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB J 15: 2365-2376, 2001.
7. Chavakis T, Santoso S, Clemetson KJ, Sachs UJ, Isordia-Salas I, Pixley RA, Nawroth PP, Colman RW, Preissner KT. High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib. J Biol Chem 278: 45375-45381, 2003.
8. Christiansen SC, Proud D, Sarnoff RB, Juergens U, Cochrane CG, Zuraw BL. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis 145: 900-905, 1992.
9. Cochrane CG, Griffin JH. The biochemistry and pathophysiology of the contact system of plasma. Adv Immunol 33: 241-306, 1982.
10. Colman RW. Contact activation pathway: inflammatory, fibrinolytic, anticoagulation, antiadhesive, and antiangiogenic activities. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice, edited by Colman RW, Hirsh J, Marder VJ, Salzman EW. Philadelphia: Lippincott, 1998, p. 1567-1583.
11. Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90: 3819-3843, 1997.
12. Emanueli C, Madeddu P. Role of the kallikrein-kinin system in the maturation of cardiovascular phenotype. Am J Hypertens 12: 988-999, 1999.
13. Espinola RG, Uknis A, Sainz IM, Isordia-Salas I, Pixley R, DeLa Cadena R, Long W, Agelan A, Gaughan J, Adam A, Colman RW. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis. Am J Pathol 165: 969-976, 2004.
14. Fernando AN, Fernando LP, Fukuda Y, Kaplan AP. Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 289: H251-H257, 2005.
15. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, Proudfoot A, Martinez AC, Dorf M, Bjerke T, Coyle AJ, Gutierrez-Ramos JC. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 188: 157-167, 1998.
16. Gustafson EJ, Schmaier AH, Wachtfogel YT, Kaufman N, Kucich U, Colman RW. Human neutrophils contain and bind high molecular weight kininogen. J Clin Invest 84: 28-35, 1989.
17. Gustafson EJ, Schutsky D, Knight LC, Schmaier AH. High molecular weight kininogen binds to unstimulated platelets. J Clin Invest 78: 310-318, 1986.
18. Hasan AA, Cines DB, Herwald H, Schmaier AH, Muller-Esterl W. Mapping the cell binding site on high molecular weight kininogen domain 5. J Biol Chem 270: 19256-19261, 1995.
19. Herwald H, Morgelin M, Svensson HG, Sjobring U. Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation. Eur J Biochem/FEBS 268: 396-404, 2001.
20. Hesselvik JF, Blomback M, Brodin B, Maller R. Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome. Crit Care Med 17: 724-733, 1989.
21. Imamura T, Tanase S, Hayashi I, Potempa J, Kozik A, Travis J. Release of a new vascular permeability enhancing peptide from kininogens by human neutrophil elastase. Biochem Biophys Res Commun 294: 423-428, 2002.
22. Jagielo PJ, Quinn TJ, Qureshi N, Schwartz DA. Grain dust-induced lung inflammation is reduced by Rhodobacter sphaeroides diphosphoryl lipid A. Am J Physiol Lung Cell Mol Physiol 274: L26-L31, 1998.
23. Kalter ES, Daha MR, ten Cate JW, Verhoef J, Bouma BN. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J Infect Dis 151: 1019-1027, 1985.
24. Khan MM, Bradford HN, Isordia-Salas I, Liu Y, Wu Y, Espinola RG, Ghebrehiwet B, Colman RW. High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes. Arterioscler Thromb Vasc Biol 26: 2260-2266, 2006.
25. Kozik A, Moore RB, Potempa J, Imamura T, Rapala-Kozik M, Travis J. A novel mechanism for bradykinin production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens. J Biol Chem 273: 33224-33229, 1998.
26. Li W, Hellsten A, Xu LH, Zhuang DM, Jansson K, Brunk UT, Yuan XM. Foam cell death induced by 7beta-hydroxycholesterol is mediated by labile iron-driven oxidative injury: mechanisms underlying induction of ferritin in human atheroma. Free Radic Biol Med 39: 864-875, 2005.
27. Lin Z, Johnson LC, Weissbach H, Brot N, Lively MO, Lowther WT. Free methionine-(R)-sulfoxide reductase from Escherichia coli reveals a new GAF domain function. Proc Natl Acad Sci USA 104: 9597-9602, 2007.
28. Little SS, Johnson DA. Human mast cell tryptase isoforms: separation and examination of substrate-specificity differences. Biochem J 307: 341-346, 1995.
29. Mahdi F, Shariat-Madar Z, Schmaier AH. The relative priority of prekallikrein and factors XI/XIa assembly on cultured endothelial cells. J Biol Chem 278: 43983-43990, 2003.
30. Maier M, Spragg J, Schwartz LB. Inactivation of human high molecular weight kininogen by human mast cell tryptase. J Immunol 130: 2352-2356, 1983.
31. McLean PG, Perretti M, Ahluwalia A. Kinin B(1) receptors and the cardiovascular system: regulation of expression and function. Cardiovasc Res 48: 194-210, 2000.
32. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM. Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci USA 88: 4946-4950, 1991.
33. Nieziolek M, Kot M, Pyka K, Mak P, Kozik A. Properties of chemically oxidized kininogens. Acta Biochim Pol 50: 753-763, 2003.
34. Parthasarathy N, Torti SV, Torti FM. Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release. Biochem J 365: 279-286, 2002.
35. Peerschke EI, Minta JO, Zhou SZ, Bini A, Gotlieb A, Colman RW, Ghebrehiwet B. Expression of gC1q-R/p33 and its major ligands in human atherosclerotic lesions. Mol Immunol 41: 759-766, 2004.
36. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551-3567, 1999.
37. Ponka P, Beaumont C, Richardson DR. Function and regulation of transferrin and ferritin. Semin Hematol 35: 35-54, 1998.
38. Raab A, Kemme M. High-molecular-weight kininogen is a binding protein for tissue prokallikrein. FEBS Lett 467: 165-168, 2000.
39. Ren S, Lawson AE, Carr M, Baumgarten CM, Schwartz LB. Human tryptase fibrinogenolysis is optimal at acidic pH and generates anticoagulant fragments in the presence of the anti-tryptase monoclonal antibody B12. J Immunol 159: 3540-3548, 1997.
40. Rodriguez RJ, White RR, Senior RM, Levine EA. Elastase release from human alveolar macrophages: comparison between smokers and nonsmokers. Science 198: 313-314, 1977.
41. Schmaier AH, Kuo A, Lundberg D, Murray S, Cines DB. The expression of high molecular weight kininogen on human umbilical vein endothelial cells. J Biol Chem 263: 16327-16333, 1988.
42. Schwartz LB, Bradford TR, Littman BH, Wintroub BU. The fibrinogenolytic activity of purified tryptase from human lung mast cells. J Immunol 135: 2762-2767, 1985.
43. Sharma JN, Thani RB. Therapeutic prospects for bradykinin receptor agonists in the treatment of cardiovascular diseases. IDrugs 7: 926-934, 2004.
44. Skidgel RA, Stanisavljevic S, Erdos EG. Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells. Biol Chem 387: 159-165, 2006.
45. Smith JJ, O'Brien-Ladner AR, Kaiser CR, Wesselius LJ. Effects of hypoxia and nitric oxide on ferritin content of alveolar cells. J Lab Clin Med 141: 309-317, 2003.
46. Stewart JM, Gera L, Chan DC, York EJ, Simkeviciene V, Bunn PA Jr, Taraseviciene-Stewart L. Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists. Peptides 26: 1288-1291, 2005.
47. Svensjo E, Batista PR, Brodskyn CI, Silva R, Lima AP, Schmitz V, Saraiva E, Pesquero JB, Mori MA, Muller-Esterl W, Scharfstein J. Interplay between parasite cysteine proteases and the host kinin system modulates microvascular leakage and macrophage infection by promastigotes of the Leishmania donovani complex. Microbes Infect 8: 206-200, 2005.
48. Telfer JF, Brock JH. Expression of ferritin, transferrin receptor, and non-specific resistance associated macrophage proteins 1 and 2 (Nramp1 and Nramp2) in the human rheumatoid synovium. Ann Rheum Dis 61: 741-744, 2002.
49. Thomas VA, Wheeless CJ, Stack MS, Johnson DA. Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption. Biochemistry 37: 2291-2298, 1998.
50. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 99: 3505-3516, 2002.
51. Torti SV, Torti FM. Human H-kininogen is a ferritin-binding protein. J Biol Chem 273: 13630-13635, 1998.
52. Turi JL, Yang F, Garrick MD, Piantadosi CA, Ghio AJ. The iron cycle and oxidative stress in the lung. Free Radic Biol Med 36: 850-857, 2004.
53. Vogel R, Assfalg-Machleidt I, Esterl A, Machleidt W, Muller-Esterl W. Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctions. J Biol Chem 263: 12661-12668, 1988.
54. Waki H, Yamauchi T, Kamon J, Kita S, Ito Y, Hada Y, Uchida S, Tsuchida A, Takekawa S, Kadowaki T. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 146: 790-796, 2005.
55. Wei Y, Miller SC, Tsuji Y, Torti SV, Torti FM. Interleukin 1 induces ferritin heavy chain in human muscle cells. Biochem Biophys Res Commun 169: 289-296, 1990.
56. Yang C, Wang J, Krutchinsky AN, Chait BT, Morrisett JD, Smith CV. Selective oxidation in vitro by myeloperoxidase of the N-terminal amine in apolipoprotein B-100. J Lipid Res 42: 1891-1896, 2001.
57. Yarovaya GA, Blokhina TB, Neshkova Contact system EA. New concepts on activation mechanisms and bioregulatory functions. Biochemistry 67: 13-24, 2002.